title: Glisson's capsule blistering after hyperthermic intraperitoneal chemotherapy.
abstract: Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson's capsule has not been previously reported as a consequence of this treatment modality. Patient do not experiment any associated morbidity.
authors.affiliation: Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), México, D.F. herimd@hotmail.com
authors.forename: Heriberto
authors.initials: H
authors.lastname: Medina-Franco
authors.forename: Daniel
authors.initials: D
authors.lastname: Zamora-Valdés
authors.forename: Ariadne
authors.initials: A
authors.lastname: Sánchez-Ramón
authors.forename: Gabriela
authors.initials: G
authors.lastname: Trejo-Gómez
mesh_terms: D001768:Blister / Q000209:etiology* / Q000473:pathology*; D003131:Combined Modality Therapy; D003238:Connective Tissue / Q000473:pathology*; D004358:Drug Therapy / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects* / Q000379:methods; D007263:Infusions, Parenteral; D008099:Liver / Q000473:pathology*; D008875:Middle Aged; D018297:Neoplasms, Cystic, Mucinous, and Serous / Q000556:secondary / Q000628:therapy; D010051:Ovarian Neoplasms / Q000473:pathology / Q000628:therapy; D010534:Peritoneal Neoplasms / Q000556:secondary / Q000628:therapy; D016896:Treatment Outcome